About
Leapfrog Bio develops precision oncology therapies by identifying and targeting genetic vulnerabilities in cancers driven by loss-of-function mutations using its proprietary OncoSLX platform to repurpose clinical-stage drugs.
Explore Leapfrog Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.